The pharmaceutical industry stands at the precipice of a transformative era. As the Drug Supply Chain Security Act (DSCSA) mandates inch closer to full enforcement, stakeholders are under increasing pressure to ensure compliance. Concurrently, industry leaders are gearing up for the PACK EXPO
October 2, 2024
Aramex's recent achievement of receiving the Good Distribution Practice (GDP) certification for Quality and Freight in the UAE marks a significant milestone in the company's journey as a trusted partner in the region's healthcare supply chain. This certification underscores
September 19, 2024
In recent years, the pharmaceutical industry has witnessed a significant shift towards direct-to-consumer (DTC) sales and services. Pharmaceutical companies are increasingly moving to sell their products directly to consumers, bypassing traditional intermediaries like wholesalers, distributors, and
September 17, 2024
UPS's recent acquisition of Frigo-Trans and BPL marks a significant development in the healthcare logistics sector. This strategic move is set to bolster UPS’s ability to handle temperature-sensitive and time-critical logistics across Europe. This acquisition comes at a time when the p
September 12, 2024
Johnson & Johnson (J&J) recently announced a significant shift in their approach to the 340B drug discount program, aiming to change how discounts are offered for crucial medications. This policy adjustment is set to take effect on October 15, 2024, and has raised considerable concerns
August 27, 2024
The Democratic National Convention (DNC) set the stage for critical discussions on the current U.S. political and health landscape. The event focused on the healthcare policies of Vice President Kamala Harris and her running mate, Minnesota Governor Tim Walz. Additionally, the convention addressed
August 22, 2024
